<DOC>
	<DOCNO>NCT00967317</DOCNO>
	<brief_summary>To evaluate efficacy tolerability Auris-Sedina symptomatic control otalgy patient without acute external otitis compare use Otosynalar® .</brief_summary>
	<brief_title>Phase III Open Study , Prospective , Multicenter , Randomized , Comparative Positive Control Evaluating Efficacy Safety Auris-Sedina Symptomatic Control Otalgy Patients With Without Acute External Otitis .</brief_title>
	<detailed_description>Phase III open Study , multicenter , prospective , randomize entrance total 188 patient , 94 patient receive medication test 94 patient receive Otosynalar® . Patients assess clinical condition resolve maximum 3 day . 188 patient either gender race , least two follow symptom : pain , discharge , tinnitus , ear fullness , subjective hearing loss temporary dizziness vertigo . And clinical non-acute external otitis .</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Externa</mesh_term>
	<criteria>Patients otalgy , acute external otitis ; Patients least two symptom otalgy ( pain , discharge , tinnitus , ear fullness , subjective hearing loss temporary dizziness vertigo ) Visual Analogic Scale score 4 8 ( mild moderate ) ; The patient must present otalgia one ear ; Children 6 year age ; Adults 18 year age ; Patients consent participate study ; Patients female childbearing age use reliable method contraception negative pregnancy test . Patients sensitivity component formula ; Patients pregnant lactating ; Non visualization tympanic membrane obstruction cerumen ; Patients evidence wound scratch ear ( ulcerative lesion ) ; Patients make use medication might interfere evaluation effectiveness study ( antibiotic , antiinflammatory , solution ear ) ; Patients severe classification Visual Analogic Scale score 9 10 symptom list questionnaire ; Patients otalgy otological origin ; Patients otitis , except acute external otitis ; Patients epiglottitis ; The patient infection ; Patients follow procedure clarify protocol .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Auris-Sedina</keyword>
	<keyword>Otitis</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Tolerability</keyword>
</DOC>